Mobile version Change to english Cambiar a espaƱol Canviar a catala Mudar para portugues Wechseln um Deutsch

Diretrizes clínicas


  1. Adams, P. C., Reboussin, D. M., Barton, J. C., McLaren, C. E., Eckfeldt, J. H., McLaren, G. D., et al. (2005). Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med, 352(17), 1769-1778.
  2. Alberti, K. G., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., et al. (2009). Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation, 120(16), 1640-1645.
  3. Altés, A., Alústiza, J. M., Arrizabalaga, B., González, F. A., Matute, F., Remacha, A., et al. (2012). Utilidad de la resonancia magnética en el diagnóstico de la sobrecarga férrica. . Barcelona: Novartis Farmacéutica, SA
  4. Altés, A., Remacha, A. F., Sureda, A., Martino, R., Briones, J., Brunet, S., et al. (2003). Patients with biochemical iron overload: causes and characteristics of a cohort of 150 cases. Ann Hematol, 82(2), 127-130.
  5. Allen, K. J., Bertalli, N. A., Osborne, N. J., Constantine, C. C., Delatycki, M. B., Nisselle, A. E., et al. (2010). HFE Cys282Tyr homozygotes with serum ferritin concentrations below 1000 microg/L are at low risk of hemochromatosis. Hepatology, 52(3), 925-933.
  6. Bacon, B. R., Adams, P. C., Kowdley, K. V., Powell, L. W., & Tavill, A. S. (2011). Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology, 54(1), 328-343.
  7. Balwani, M., & Desnick, R. J. (2012). The porphyrias: advances in diagnosis and treatment. Blood, 120(23), 4496-4504.
  8. Beaton, M. D., & Adams, P. C. (2012). Treatment of hyperferritinemia. Ann Hepatol, 11(3), 294-300.
  9. Brissot, P., Bardou-Jacquet, E., Jouanolle, A. M., & Loreal, O. (2011). Iron disorders of genetic origin: a changing world. Trends Mol Med, 17(12), 707-713.
  10. Caballeria, J., & Parés, A. (2012). Hepatopatías alcohólicas In Farreras-Rozman (Ed.), Medicina Interna (XVII ed., pp. 326). Barcelona: Elsevier.
  11. Camaschella, C., Roetto, A., Cali, A., De Gobbi, M., Garozzo, G., Carella, M., et al. (2000). The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet, 25(1), 14-15.
  12. Cazzola, M., Bergamaschi, G., Tonon, L., Arbustini, E., Grasso, M., Vercesi, E., et al. (1997). Hereditary hyperferritinemia-cataract syndrome: relationship between phenotypes and specific mutations in the iron-responsive element of ferritin light-chain mRNA. Blood, 90(2), 814-821.
  13. Chang, T. P., & Rangan, C. (2011). Iron poisoning: a literature-based review of epidemiology, diagnosis, and management. Pediatr Emerg Care, 27(10), 978-985.
  14. Crook, M.A. (2012). Hyperferritinemia; laboratory implications. Ann Clin Biochem, 49(Pt3),211-213.
  15. Desai, T. K., Jamil, L. H., Balasubramaniam, M., Koff, R., & Bonkovsky, H. L. (2008). Phlebotomy improves therapeutic response to interferon in patients with chronic hepatitis C: a meta-analysis of six prospective randomized controlled trials. Dig Dis Sci, 53(3), 815-822.
  16. Díez-Sáez, C., Esteban-López, J., & Ayala-Curiel, J. (2003). Intoxicación por hierro y otros metales. In Mintegui S. Grupo de Trabajo de Intoxicaciones. Manual de intoxicaciones en pediatría. Madrid: Ediciones Ergon SA.
  17. EASL clinical practice guidelines for HFE hemochromatosis. (2010). J Hepatol, 53(1), 3-22.
  18. Fontana, R. J., Israel, J., LeClair, P., Banner, B. F., Tortorelli, K., Grace, N., et al. (2000). Iron reduction before and during interferon therapy of chronic hepatitis C: results of a multicenter, randomized, controlled trial. Hepatology, 31(3), 730-736.
  19. Freixenet, N., Moreno-Rosel, M. S., Barcelo, M. J., Serrano, A., Paya, M., Crespo, L., et al. (2010). Detection of hereditary hemochromatosis and biochemical iron overload in primary care: a multicenter case finding study in Spain. Am J Hematol, 85(4), 294-296.
  20. Gentile, I., Viola, C., Paesano, L., D'Onofrio, M., D'Agostino, E., Cerini, R., et al. (2009). Iron depletion before HCV antiviral therapy: a pilot, randomized, controlled trial. J Clin Apher, 24(5), 190-196.
  21. Gimferrer, E., Úbeda, J., Royo, M. T., & Marigó, G. J. (1998). Importancia clínica de la hiperferritinemia Bio-Ferrum 3, 17-32.
  22. Girelli, D., Olivieri, O., Gasparini, P., & Corrocher, R. (1996). Molecular basis for the hereditary hyperferritinemia-cataract syndrome. Blood, 87(11), 4912-4913.
  23. Guyader, D., Jacquelinet, C., Moirand, R., Turlin, B., Mendler, M. H., Chaperon, J., et al. (1998). Noninvasive prediction of fibrosis in C282Y homozygous hemochromatosis. Gastroenterology, 115(4), 929-936.
  24. Harrison-Findik, D. D. (2007). Role of alcohol in the regulation of iron metabolism. World J Gastroenterol, 13(37), 4925-4930.
  25. Henter, J. I., Horne, A., Arico, M., Egeler, R. M., Filipovich, A. H., Imashuku, S., et al. (2007). HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer, 48(2), 124-131.
  26. Jacobs, A. (1984). Serum ferritin and malignant tumours. Med Oncol Tumor Pharmacother, 1(3), 149-156.
  27. Kannengiesser, C., Jouanolle, A. M., Hetet, G., Mosser, A., Muzeau, F., Henry, D., et al. (2009). A new missense mutation in the L ferritin coding sequence associated with elevated levels of glycosylated ferritin in serum and absence of iron overload. Haematologica, 94(3), 335-339.
  28. Kohgo, Y., Ohtake, T., Ikuta, K., Suzuki, Y., Torimoto, Y., & Kato, J. (2008). Dysregulation of systemic iron metabolism in alcoholic liver diseases. J Gastroenterol Hepatol, 23 Suppl 1, S78-81.
  29. Kushner, I. (1982). The phenomenon of the acute phase response. Ann N Y Acad Sci, 389, 39-48.
  30. Le Gac, G., & Ferec, C. (2005). The molecular genetics of haemochromatosis. Eur J Hum Genet, 13(11), 1172-1185.
  31. Lin, T. F., Ferlic-Stark, L. L., Allen, C. E., Kozinetz, C. A., & McClain, K. L. (2011). Rate of decline of ferritin in patients with hemophagocytic lymphohistiocytosis as a prognostic variable for mortality. Pediatr Blood Cancer, 56(1), 154-155.
  32. Ludwig, J., Batts, K. P., Moyer, T. P., Baldus, W. P., & Fairbanks, V. F. (1993). Liver biopsy diagnosis of homozygous hemochromatosis: a diagnostic algorithm. Mayo Clin Proc, 68(3), 263-267.
  33. Luscieti, S., Tolle, G., Aranda, J., Campos, C. B., Risse, F., Moran, E., et al. (2013). Novel mutations in the ferritin-L iron-responsive element that only mildly impair IRP binding cause hereditary hyperferritinemia cataract syndrome. Orphanet J Rare Dis, 8(1), 30.
  34. Mateo-Gallego, R., Calmarza, P., Jarauta, E., Burillo, E., Cenarro, A., & Civeira, F. (2010). Serum ferritin is a major determinant of lipid phenotype in familial combined hyperlipidemia and familial hypertriglyceridemia. Metabolism, 59(2), 154-158.
  35. McGill, D. B., Rakela, J., Zinsmeister, A. R., & Ott, B. J. (1990). A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology, 99(5), 1396-1400.
  36. Moirand, R., Mortaji, A. M., Loreal, O., Paillard, F., Brissot, P., & Deugnier, Y. (1997). A new syndrome of liver iron overload with normal transferrin saturation. Lancet, 349(9045), 95-97.
  37. Morrison, E. D., Brandhagen, D. J., Phatak, P. D., Barton, J. C., Krawitt, E. L., El-Serag, H. B., et al. (2003). Serum ferritin level predicts advanced hepatic fibrosis among U.S. patients with phenotypic hemochromatosis. Ann Intern Med, 138(8), 627-633.
  38. Njajou, O. T., Vaessen, N., Joosse, M., Berghuis, B., van Dongen, J. W., Breuning, M. H., et al. (2001). A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat Genet, 28(3), 213-214.
  39. Ogilvie, C., Fitzsimons, K., & Fitzsimons, E. J. (2010). Serum ferritin values in primary care: are high values overlooked? J Clin Pathol, 63(12), 1124-1126.
  40. Olynyk, J. K., O'Neill, R., Britton, R. S., & Bacon, B. R. (1994). Determination of hepatic iron concentration in fresh and paraffin-embedded tissue: diagnostic implications. Gastroenterology, 106(3), 674-677.
  41. Papanikolaou, G., Samuels, M. E., Ludwig, E. H., MacDonald, M. L., Franchini, P. L., Dube, M. P., et al. (2004). Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet, 36(1), 77-82.
  42. Piccinino, F., Sagnelli, E., Pasquale, G., & Giusti, G. (1986). Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. J Hepatol, 2(2), 165-173.
  43. Pietrangelo, A. (2004). Hereditary hemochromatosis--a new look at an old disease. N Engl J Med, 350(23), 2383-2397.
  44. Pietrangelo, A. (2010). Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment. Gastroenterology, 139(2), 393-408, 408 e391-392.
  45. Roetto, A., Papanikolaou, G., Politou, M., Alberti, F., Girelli, D., Christakis, J., et al. (2003). Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet, 33(1), 21-22.
  46. Roy, C. N. (2010). Anemia of inflammation. Hematology Am Soc Hematol Educ Program, 2010, 276-280.
  47. Ryan Caballes, F., Sendi, H., & Bonkovsky, H. L. (2012). Hepatitis C, porphyria cutanea tarda and liver iron: an update. Liver Int, 32(6), 880-893.
  48. Saglini, V., & Brissot, P. (2012). [Hyperferritinemia--Algorithm]. Rev Med Suisse, 8(342), 1135-1137.
  49. Tavill, A. S. (2001). Diagnosis and management of hemochromatosis. Hepatology, 33(5), 1321-1328.
  50. Thurlow, V., Vadher, B., Bomford, A., DeLord, C., Kannengiesser, C., Beaumont, C., et al. (2012). Two novel mutations in the L ferritin coding sequence associated with benign hyperferritinemia unmasked by glycosylated ferritin assay. Ann Clin Biochem, 49(Pt 3), 302-305.
  51. Valenti, L., Fracanzani, A. L., Dongiovanni, P., Bugianesi, E., Marchesini, G., Manzini, P., et al. (2007). Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study. Am J Gastroenterol, 102(6), 1251-1258.
  52. Waalen, J., Felitti, V. J., Gelbart, T., & Beutler, E. (2008). Screening for hemochromatosis by measuring ferritin levels: a more effective approach. Blood, 111(7), 3373-3376.
  53. Wang, W., Knovich, M. A., Coffman, L. G., Torti, F. M., & Torti, S. V. (2010). Serum ferritin: Past, present and future. Biochim Biophys Acta, 1800(8), 760-769.
  54. Zacharski, L. R., Ornstein, D. L., Woloshin, S., & Schwartz, L. M. (2000). Association of age, sex, and race with body iron stores in adults: analysis of NHANES III data. Am Heart J, 140(1), 98-104.
  55. Zanella, A., Gridelli, L., Berzuini, A., Colotti, M. T., Mozzi, F., Milani, S., et al. (1989). Sensitivity and predictive value of serum ferritin and free erythrocyte protoporphyrin for iron deficiency. J Lab Clin Med, 113(1), 73-78.
Sello de calidad Medicina XXI
Aviso legal IMPPC © Última actualização: Outubro de 2014
Ir ao inicio